TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000855 |
| _version_ | 1827295943636025344 |
|---|---|
| author | Riccardo Bomben Antonella Zucchetto Federico Pozzo Erika Tissino Tamara Bittolo Jacopo Olivieri Annalisa Chiarenza Francesco Zaja Maria Ilaria Del Principe Davide Rossi Valter Gattei |
| author_facet | Riccardo Bomben Antonella Zucchetto Federico Pozzo Erika Tissino Tamara Bittolo Jacopo Olivieri Annalisa Chiarenza Francesco Zaja Maria Ilaria Del Principe Davide Rossi Valter Gattei |
| author_sort | Riccardo Bomben |
| collection | DOAJ |
| first_indexed | 2024-04-24T14:29:43Z |
| format | Article |
| id | doaj.art-1c4612854aa84ec18b24849810540068 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-04-24T14:29:43Z |
| publishDate | 2023-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1c4612854aa84ec18b248498105400682024-04-03T03:31:55ZengWileyHemaSphere2572-92412023-04-0174e85510.1097/HS9.0000000000000855202304000-00014TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?Riccardo Bomben0Antonella Zucchetto1Federico Pozzo2Erika Tissino3Tamara Bittolo4Jacopo Olivieri5Annalisa Chiarenza6Francesco Zaja7Maria Ilaria Del Principe8Davide Rossi9Valter Gattei101 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy1 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy1 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy1 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy1 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italy2 Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy3 Division of Haematology, Ferrarotto Hospital, Catania, Italy4 Department of Medical, Surgical and Health Sciences, University of Trieste, Italy5 Division of Haematology, University of Tor Vergata, Rome, Italy6 Haematology, Institute of Oncology Research, Bellinzona, Switzerland1 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano (PN), Italyhttp://journals.lww.com/10.1097/HS9.0000000000000855 |
| spellingShingle | Riccardo Bomben Antonella Zucchetto Federico Pozzo Erika Tissino Tamara Bittolo Jacopo Olivieri Annalisa Chiarenza Francesco Zaja Maria Ilaria Del Principe Davide Rossi Valter Gattei TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? HemaSphere |
| title | TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? |
| title_full | TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? |
| title_fullStr | TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? |
| title_full_unstemmed | TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? |
| title_short | TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed? |
| title_sort | tp53 mutations and clinical outcome in chronic lymphocytic leukemia is a threshold still needed |
| url | http://journals.lww.com/10.1097/HS9.0000000000000855 |
| work_keys_str_mv | AT riccardobomben tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT antonellazucchetto tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT federicopozzo tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT erikatissino tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT tamarabittolo tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT jacopoolivieri tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT annalisachiarenza tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT francescozaja tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT mariailariadelprincipe tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT daviderossi tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded AT valtergattei tp53mutationsandclinicaloutcomeinchroniclymphocyticleukemiaisathresholdstillneeded |